Skip to main content
Premium Trial:

Request an Annual Quote

CLC Bio Opens New Offices in US

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CLC Bio today said that it has opened two new offices in the US: an Americas headquarters in Cambridge, Mass., and a Government Sector Branch in Germantown, Md.

CLC said that the Cambridge office will be the home base for its sales, marketing, and support operations in North and South America. The Aarhus, Denmark-based firm also said that it has hired several new employees this year and plans to employ additional staff for its US team.

"Our customers and partners are clearly members of a global industry and we strongly believe that we need a significant presence in both North and South America in order to serve their interest," Dan Conway, CLC Bio's president of the Americas, said in a statement.

Two weeks ago, CLC had announced plans to expand in Japan through an alliance with World Fusion that included the creation of a sequencing analysis services center.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.